In addition, although gemcitabine, a cytotoxic agent, can inhibit CD133 + stemness proliferation, it has little effect on the apoptosis of cancer stemness, allowing them to return to the stemness pool upon gemcitabine withdrawal [176]. This evidence concerns the gene PROM1 and cancer.